Hennion & Walsh Asset Management’s Sage Therapeutics SAGE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-14,828
| Closed | -$118K | – | 949 |
|
|
2025
Q1 | $118K | Sell |
14,828
-3,418
| -19% | -$27.2K | 0.01% | 853 |
|
|
2024
Q4 | $99.1K | Sell |
18,246
-21,172
| -54% | -$115K | ﹤0.01% | 841 |
|
|
2024
Q3 | $285K | Sell |
39,418
-2,419
| -6% | -$17.5K | 0.01% | 748 |
|
|
2024
Q2 | $454K | Sell |
41,837
-24,730
| -37% | -$269K | 0.02% | 613 |
|
|
2024
Q1 | $1.25M | Buy |
66,567
+5,068
| +8% | +$95K | 0.07% | 368 |
|
|
2023
Q4 | $1.33M | Sell |
61,499
-23,996
| -28% | -$520K | 0.08% | 334 |
|
|
2023
Q3 | $1.76M | Buy |
85,495
+4,262
| +5% | +$87.7K | 0.11% | 234 |
|
|
2023
Q2 | $3.82M | Buy |
81,233
+8,476
| +12% | +$399K | 0.23% | 112 |
|
|
2023
Q1 | $3.05M | Buy |
72,757
+1,740
| +2% | +$73K | 0.19% | 139 |
|
|
2022
Q4 | $2.71M | Sell |
71,017
-9,373
| -12% | -$358K | 0.17% | 157 |
|
|
2022
Q3 | $3.15M | Buy |
80,390
+1,972
| +3% | +$77.2K | 0.21% | 134 |
|
|
2022
Q2 | $2.53M | Buy |
78,418
+15,866
| +25% | +$512K | 0.16% | 167 |
|
|
2022
Q1 | $2.07M | Buy |
62,552
+10,264
| +20% | +$340K | 0.11% | 218 |
|
|
2021
Q4 | $2.22M | Buy |
52,288
+14,393
| +38% | +$612K | 0.11% | 220 |
|
|
2021
Q3 | $1.68M | Sell |
37,895
-835
| -2% | -$37K | 0.09% | 260 |
|
|
2021
Q2 | $2.2M | Sell |
38,730
-421
| -1% | -$23.9K | 0.12% | 234 |
|
|
2021
Q1 | $2.93M | Buy |
+39,151
| New | +$2.93M | 0.18% | 165 |
|